R1 RCM Holdco Inc
F:6HL0
R1 RCM Holdco Inc
F:6HL0
Price:
11.6 EUR
1.75%
Updated:
May 29, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
12.4
Current
23.9
Median
12.8
Industry
Lower
than median
Lower
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=12.4
Enterprise Value
/
6.2B
EBITDA
539.2m
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| US |
|
R1 RCM Holdco Inc
F:6HL0
|
4.9B EUR | 12.4 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
87.4B EUR | 9.5 | |
| US |
|
Cigna Corp
NYSE:CI
|
94.7B USD | 9.5 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
67.1B USD | 8.4 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
16.4B EUR | 10.4 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
16.5B USD | 11.7 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
15.4B USD | 10.9 | |
| US |
|
DaVita Inc
NYSE:DVA
|
12.6B USD | 8.5 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.3B EUR | 6.5 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
11.3B EUR | 6.5 | |
| US |
|
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | -23.3 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
10.3
2-Years Forward
EV/EBITDA
8.6
3-Years Forward
EV/EBITDA
7.6
You don't have any saved screeners yet
